6,352
Views
40
CrossRef citations to date
0
Altmetric
Editorial

The power of tears: how tear proteomics research could revolutionize the clinic

&
Pages 189-191 | Received 19 Dec 2016, Accepted 19 Jan 2017, Published online: 01 Feb 2017

References

  • Zhou L, Beuerman RW. Tear analysis in ocular surface diseases. Prog Retin Eye Res. 2012;31(6):527–550.
  • Aranha Dos Santos V, Schmetterer L, Gröschl M, et al. In vivo tear film thickness measurement and tear film dynamics visualization using spectral domain optical coherence tomography. Opt Express. 2015;23(16):21043–21063.
  • Zhou L, Zhao SZ, Koh SK, et al. In-depth analysis of the human tear proteome. J Proteomics. 2012;75(13):3877–3885.
  • Tong L, Zhou XY, Jylha A, et al. Quantitation of 47 human tear proteins using high resolution multiple reaction monitoring (HR-MRM) based-mass spectrometry. J Proteomics. 2015;115:36–48.
  • Chen L, Zhou L, Chan ECY, et al. Characterization of the human tear metabolome by LC-MS/MS. J Proteome Res. 2011;10(10):4876–4882.
  • Butovich IA. Tear film lipids. Exp Eye Res. 2013;117:4–27.
  • Ozcan S, An HJ, Vieira AC, et al. Characterization of novel O-glycans isolated from tear and saliva of ocular rosacea patients. J Proteome Res. 2013;12(3):1090–1100.
  • Nguyen-Khuong T, Everest-Dass AV, Kautto L, et al. Glycomic characterization of basal tears and changes with diabetes and diabetic retinopathy. Glycobiology. 2015;25(3):269–283.
  • Zhou L, Beuerman RW, Chan CM, et al. Identification of tear fluid biomarkers in dry eye syndrome using iTRAQ quantitative proteomics. J Proteome Res. 2009;8(11):4889–4905.
  • Srinivasan S, Thangavelu M, Zhang L, et al. iTRAQ quantitative proteomics in the analysis of tears in dry eye patients. Invest Ophthalmol Vis Sci. 2012;53(8):5052–5059.
  • Li B, Sheng M, Li J, et al. Tear proteomic analysis of Sjögren syndrome patients with dry eye syndrome by two-dimensional-nano-liquid chromatography coupled with tandem mass spectrometry. Sci Rep. 2014;4:5772.
  • Perumal N, Funke S, Pfeiffer N, et al. Proteomics analysis of human tears from aqueous-deficient and evaporative dry eye patients. Sci Rep. 2016;6:29629.
  • Zhou L, Wei R, Zhao P, et al. Proteomic analysis revealed the altered tear protein profile in a rabbit model of Sjögren’s syndrome-associated dry eye. Proteomics. 2013;13(16):2469–2481.
  • Tong L, Zhou L, Beuerman RW, et al. Association of tear proteins with Meibomian gland disease and dry eye symptoms. Br J Ophthalmol. 2011;95(6):848–852.
  • Lam SM, Tong L, Duan X, et al. Longitudinal changes in tear fluid lipidome brought about by eyelid-warming treatment in a cohort of meibomian gland dysfunction. J Lipid Res. 2014;55(9):1959–1969.
  • D’Souza S, Petznick A, Tong L, et al. Comparative analysis of two femtosecond LASIK platforms using iTRAQ quantitative proteomics. Invest Ophthalmol Vis Sci. 2014;55(6):3396–3402.
  • Petznick A, Chew A, Hall RC, et al. Comparison of corneal sensitivity, tear function and corneal staining following laser in situ keratomileusis with two femtosecond laser platforms. Clin Ophthalmol. 2013;7:591–598.
  • Wong TT, Zhou L, Li J, et al. Proteomic profiling of inflammatory signaling molecules in the tears of patients on chronic glaucoma medication. Invest Ophthalmol Vis Sci. 2011;52(10):7385–7391.
  • Kramann C, Boehm N, Lorenz K, et al. Effect of contact lenses on the protein composition in tear film: a ProteinChip study. Graefes Arch Clin Exp Ophthalmol. 2011;249:233–243.
  • Lema I, Brea D, Rodríguez-González R, et al. Proteomic analysis of the tear film in patients with keratoconus. Mol Vis. 2010;16:2055–2061.
  • Matheis N, Grus FH, Breitenfeld M, et al. Proteomics differentiate between thyroid-associated orbitopathy and dry eye syndrome. Invest Ophthalmol Vis Sci. 2015;56(4):2649–2656.
  • Leonardi A, Palmigiano A, Mazzola EA, et al. Identification of human tear fluid biomarkers in vernal keratoconjunctivitis using iTRAQ quantitative proteomics. Allergy. 2014;69(2):254–260.
  • Kim HJ, Kim P-K, Yoo H-S, et al. Comparison of tear proteins between healthy and early diabetic retinopathy patients. Clin Biochem. 2012;45(1–2):60–67.
  • Pieragostino D, Agnifili L, Fasanella V, et al. Shotgun proteomics reveals specific modulated protein patterns in tears of patients with primary open angle glaucoma naïve to therapy. Mol Biosyst. 2013;9(6):1108–1116.
  • Böhm D, Keller K, Pieter J, et al. Comparison of tear protein levels in breast cancer patients and healthy controls using a de novo proteomic approach. Oncol Rep. 2012;28(2):429–438.
  • Li B, Sheng M, Xie L, et al. Tear proteomic analysis of patients with type 2 diabetes and dry eye syndrome by two-dimensional nano-liquid chromatography coupled with tandem mass spectrometry. Invest Ophthalmol Vis Sci. 2014;55(1):177–186.
  • Kalló G, Emri M, Varga Z, et al. Changes in the chemical barrier composition of tears in Alzheimer’s disease reveal potential tear diagnostic biomarkers. PLoS One. 2016;11(6):e0158000.
  • Sajic T, Liu Y, Aebersold R, et al. Tear fluid protein changes in dry eye syndrome associated with rheumatoid arthritis: a proteomic approach. Ocul Surf. 2017;15(1):112–129.
  • Sajic T, Liu Y, Aebersold R. Using data-independent, high-resolution mass spectrometry in protein biomarker research: perspectives and clinical applications. Proteomics Clin Appl. 2015;9(3–4):307–321.
  • Paglia G, Kliman M, Claude E, et al. Applications of ion-mobility mass spectrometry for lipid analysis. Anal Bioanal Chem. 2015;407(17):4995–5007.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.